Clinical Trials Logo

Clinical Trial Summary

Diabetes mellitus is the most common endocrine disorder, causes many complications such as micro- and macro-vascular diseases. Various kinds of antidiabetic drugs have been developed, but most of them have side effects. Recently, the use of natural plant products has gained more attention among scientists in order to prevent diabetic vascular complications. Curcumin is a natural yellow product derived from the turmeric rhizome which has shown to be non-toxic and exhibits various bio¬logical activities such as anti-oxidant, anti-inflammatory, anti-carcinogenic, and anti-diabetic effects. Curcumin is effective in reducing glycemic index and hyperlipidemia in rodent models and is relatively inexpensive and safe. Most of the studies conducted on animal model, and just a few of them are on human model. The present study was planned to evaluate the effects of curcumin supplementation The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02529982
Study type Interventional
Source National Nutrition and Food Technology Institute
Contact
Status Completed
Phase N/A
Start date July 2015
Completion date April 2016

See also
  Status Clinical Trial Phase
Recruiting NCT03073343 - A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine N/A
Recruiting NCT02529969 - Effects of Curcumin Supplementation on Lipid Profile and Inflammatory Markers of Patients With Type 2 Diabetes Phase 2/Phase 3
Recruiting NCT01745900 - Evaluation and Comparison of Noninvasive Blood Glucose Concentrations N/A
Completed NCT00835861 - Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes Phase 2